Precision therapies reshape the fight against glioblastoma multiforme
A new research perspective reveals how clinical trials are redefining glioblastoma treatment by combining molecular targeting, immunotherapy, and metabolic disruption.
Oncolytic virus 1 article
In this taxonomy, oncolytic virus denotes a tumor-selective viral therapy modality organized around tumor-selective viral replication and its associated workflow. Researchers encounter it through virus-mediated cancer cell lysis and intratumoral viral therapy, with engineered oncolytic viruses shaping the resulting effect or readout and tumor antigen release providing another application context. Oncolytic viruses are not simply cancer vaccines: their identity includes viral infection or replication in tumors alongside immune effects.